Topics

Evotec, CRTD partner to discover novel therapies for retinal diseases

14:45 EST 15 Dec 2017 | CentreWatch

Evotec has entered into a research collaboration with the Center for Regenerative Therapies TU Dresden (CRTD) to discover novel small molecule candidates for retinal diseases. CRTD is a recognized leader in understanding the biology of stem cells to develop new therapies for neurodegenerative and hematological diseases. Under the terms of the collaboration, Evotec will leverage […]

The post Evotec, CRTD partner to discover novel therapies for retinal diseases appeared first on CenterWatch News Online.

Original Article: Evotec, CRTD partner to discover novel therapies for retinal diseases

NEXT ARTICLE

More From BioPortfolio on "Evotec, CRTD partner to discover novel therapies for retinal diseases"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...